JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
Xenon Pharmaceuticals
XENE
$3.64B
| $82K | ﹤0.01% |
2,087
-2,184
| -51% | -$79.5K |
2020 Q4
8 quarters
|
|
|
BNT
5177
Brookfield Wealth Solutions
BNT
$10.9B
| $82K | ﹤0.01% |
3,927
+1,951
| +99% | +$51.9K |
2021 Q2
6 quarters
|
|
5178
Aemetis
AMTX
$127M
| $81K | ﹤0.01% |
20,389
+707
| +4% | +$4.02K |
2021 Q2
6 quarters
|
|
5179
Algoma Steel Group Warrant
ASTLW
$116K
| – | – |
0
| – | – |
2021 Q4
4 quarters
|
|
|
BZUN
5180
Baozun
BZUN
$191M
| $81K | ﹤0.01% |
15,453
-51,296
| -77% | -$245K |
2019 Q4
12 quarters
|
|
5181
iShares Currency Hedged MSCI Emerging Markets
HEEM
$306M
| $81K | ﹤0.01% |
+3,519
| New | +$83K |
2022 Q4
0 quarters
|
|
5182
State Street SPDR Dow Jones International Real Estate ETF
RWX
$239M
| $81K | ﹤0.01% |
3,031
+113
| +4% | +$2.89K |
2014 Q4
32 quarters
|
|
|
THRD
5183
DELISTED
Third Harmonic Bio
THRD
| $81K | ﹤0.01% |
+18,878
| New | +$316K |
2022 Q4
0 quarters
|
|
5184
Valhi
VHI
$418M
| $81K | ﹤0.01% |
3,692
+1,510
| +69% | +$36.7K |
2016 Q4
24 quarters
|
|
5185
Weave Communications
WEAV
$592M
| $81K | ﹤0.01% |
17,691
+748
| +4% | +$3.67K |
2021 Q4
4 quarters
|
|
|
ORTX
5186
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $81K | ﹤0.01% |
21,717
-538
| -2% | -$2.38K |
2019 Q4
12 quarters
|
|
5187
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$159M
| $80K | ﹤0.01% |
+3,574
| New | +$105K |
2022 Q4
0 quarters
|
|
5188
Spok Holdings
SPOK
$229M
| $80K | ﹤0.01% |
+9,772
| New | +$79.4K |
2022 Q4
0 quarters
|
|
5189
Humacyte
HUMA
$139M
| $79K | ﹤0.01% |
37,302
+19,784
| +113% | +$60.1K |
2021 Q4
4 quarters
|
|
5190
CALL
Planet Fitness
PLNT
$3.18B
| $79K | ﹤0.01% |
1,000
-52,100
| -98% | -$3.64M |
2022 Q2
2 quarters
|
|
|
CALA
5191
DELISTED
Calithera Biosciences, Inc
CALA
| $79K | ﹤0.01% |
24,345
+4,260
| +21% | +$10.2K |
2017 Q4
20 quarters
|
|
5192
Consumer Portfolio Services
CPSS
$197M
| $78K | ﹤0.01% |
8,854
-16,626
| -65% | -$119K |
2021 Q1
7 quarters
|
|
5193
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$417M
| $78K | ﹤0.01% |
+2,586
| New | +$76.7K |
2022 Q4
0 quarters
|
|
5194
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.2B
| $78K | ﹤0.01% |
2,334
+118
| +5% | +$3.99K |
2018 Q3
17 quarters
|
|
5195
InnovAge Holding
INNV
$1.23B
| $78K | ﹤0.01% |
10,827
+517
| +5% | +$3.32K |
2021 Q1
7 quarters
|
|
5196
iShares Core Moderate Allocation ETF
AOM
$1.91B
| $77K | ﹤0.01% |
2,006
+516
| +35% | +$19.6K |
2021 Q2
6 quarters
|
|
5197
VanEck IG Floating Rate ETF
FLTR
$3.41B
| $77K | ﹤0.01% |
3,076
-14,559
| -83% | -$361K |
2020 Q4
8 quarters
|
|
|
MREO
5198
Mereo BioPharma
MREO
$62M
| $77K | ﹤0.01% |
145,259
+132,757
| +1,062% | +$109K |
2021 Q3
5 quarters
|
|
5199
NI Holdings
NODK
$305M
| $77K | ﹤0.01% |
5,790
+1,231
| +27% | +$16.8K |
2017 Q4
20 quarters
|
|
5200
ProShares UltraShort QQQ
QID
$210M
| $77K | ﹤0.01% |
+590
| New | +$73.2K |
2022 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.